US Stock MarketDetailed Quotes

DAWN Day One Biopharmaceuticals

Watchlist
  • 8.280
  • +0.120+1.47%
Close Mar 19 16:00 ET
  • 7.840
  • -0.440-5.31%
Pre 04:12 ET
839.22MMarket Cap-8.12P/E (TTM)

About Day One Biopharmaceuticals Company

Day One Biopharmaceuticals, Inc. operates as a holding company. The firm through its subsidiary develops and commercializes targeted therapies for patients of all ages with genetically defined cancers. Its products include DAY101 and pimsertib. The company was founded by Julie Grant and Samuel Blackman in November 2018 and is headquartered in Brisbane, CA.

Company Profile

SymbolDAWN
Company NameDay One Biopharmaceuticals
Listing DateMay 27, 2021
Issue Price16.00
Founded2018
CEODr. Jeremy Bender, M.B.A.,PhD
MarketNASDAQ
Employees181
Fiscal Year Ends12-31
Address2000 Sierra Point Parkway,Suite 501
CityBrisbane
ProvinceCalifornia
CountryUnited States of America
Zip Code94005
Phone1-650-484-0899
Websitehttp://www.dayonebio.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Jeremy Bender, M.B.A.,PhD
  • Chief Executive Officer, President and Director
  • 6.91M
  • Adam Dubow
  • General Counsel and Chief Compliance Officer
  • 2.77M
  • Charles N. York, II
  • Principal Accounting Officer, Chief Operating Officer and Chief Financial Officer
  • 3.55M
  • Garry A. Nicholson
  • Chairman of the Board
  • 383.38K
  • Dr. William Grossman, M.D.,PhD
  • Director
  • --
  • Habib Joseph Dable
  • Director
  • --
  • Michael Gladstone
  • Independent Director
  • 342.88K
  • Scott Garland
  • Independent Director
  • 342.88K
  • Dr. John A. Josey, PhD
  • Independent Director
  • 350.75K
  • Saira Ramasastry, M.Phil,M.S.
  • Independent Director
  • 351.75K
  • Natalie C. Holles
  • Lead Independent Director
  • 352.50K

Market Insights

Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Strategy
MSTR
304.230
Coinbase
COIN
189.750
Tesla
TSLA
235.860
4
MARA Holdings
MARA
12.530
5
Taylor Morrison Home
TMHC
60.210
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma Show More
FOMC Press Conference, March 19, 2025
Monetary Policy: Navigating the Fed's Rate Cut Cycle
Changing Fed policy is altering the market math for investors.